This information is issued on behalf of Highmark Blue Shield and its affiliated Blue companies, which are independent licensees of the Blue Cross Blue Shield Association. Highmark Inc. d/b/a Highmark Blue Shield and certain of its affiliated Blue companies serve Blue Shield members in 21 counties in central Pennsylvania and 13 counties in northeastern New York. As a partner in joint operating agreements, Highmark Blue Shield also provides services in conjunction with a separate health plan in southeastern Pennsylvania. Highmark Inc. or certain of its affiliated Blue companies also serve Blue Cross Blue Shield members in 29 counties in western Pennsylvania, 13 counties in northeastern Pennsylvania, the state of West Virginia plus Washington County, Ohio, the state of Delaware and 8 counties in western New York. All references to Highmark in this document are references to Highmark Inc. d/b/a Highmark Blue Shield and/or to one or more of its affiliated Blue companies.
Population Health University is an open exchange of information with The American Journal of Managed Care® (AJMC®) designed to deliver valuable information to you so that you can improve your overall delivery of care.
A Comprehensive Approach to Fourth-Trimester Care Aims to Overcome Newborn Health Disparities
November 8th 2023Care in the fourth-trimester, when the birth has taken place and the mother and baby return home, is crucial for the well-being of the mother or the birthing person, Takiyah Durham, MBA, explains in an interview.
Watch
Alignment Between Manufacturers, Payers Key to Improving Specialty Drug Affordability and Access
June 22nd 2022Panelists taking part in an AHIP 2022 session discuss collaborative strategies among payers, manufacturers, and policy makers to address challenges regarding affordability and access of novel disease modifying drugs entering the marketplace.
Read More
Appropriate ED Utilization Leading to Better Care Coordination
Addressing avoidable emergency department (ED) utilization takes interventions in partnership with providers.
Read More
What We’re Reading: Combating Drug Prices; Fauci Warns on Delta Variant; Health Care Gaps
June 23rd 2021Blue Cross Blue Shield aims to fight increasing drug prices with a new pharmacy solutions company; Anthony Fauci, MD, warns about the growing threat from the Delta variant; COVID-19–related death rates highest in Texas border counties.
Read More
Empagliflozin Linked to 20% Drop in Care Costs for T2D, CVD
December 15th 2020An outcomes-based agreement conducted by Boehringer Ingelheim and Highmark found that use of Jardiance (empagliflozin) among adults with type 2 diabetes (T2D) and known cardiovascular disease (CVD) was associated with a total cost of care savings of over 20%.
Read More